Anthem Inc.’s new cancer treatment pathways program is expected to save the insurer 3% to 4% in cancer care costs annually once it is fully implemented.
The pathways initiative, which could eventually cover more than 21 million commercial and Medicare Advantage members, will offer reimbursement incentives to oncologists to compare planned cancer treatment regimens against evidence-based...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?